APA (7th ed.) Citation

M, V., MF, A. R., FS, M., AC, C., & MA, I. (1998). N-formyl-methionyl-leucyl-phenylalanine (fMLP) inhibits tumour necrosis factor-alpha (TNF-alpha) production on lipopolysaccharide (LPS)-stimulated human neutrophils. Clinical and experimental immunology, 113(1), 39. https://doi.org/10.1046/j.1365-2249.1998.00631.x

Chicago Style (17th ed.) Citation

M, Vulcano, Alves Rosa MF, Minnucci FS, Cherñavsky AC, and Isturiz MA. "N-formyl-methionyl-leucyl-phenylalanine (fMLP) Inhibits Tumour Necrosis Factor-alpha (TNF-alpha) Production on Lipopolysaccharide (LPS)-stimulated Human Neutrophils." Clinical and Experimental Immunology 113, no. 1 (1998): 39. https://doi.org/10.1046/j.1365-2249.1998.00631.x.

MLA (9th ed.) Citation

M, Vulcano, et al. "N-formyl-methionyl-leucyl-phenylalanine (fMLP) Inhibits Tumour Necrosis Factor-alpha (TNF-alpha) Production on Lipopolysaccharide (LPS)-stimulated Human Neutrophils." Clinical and Experimental Immunology, vol. 113, no. 1, 1998, p. 39, https://doi.org/10.1046/j.1365-2249.1998.00631.x.